Neuren Pharmaceuticals | NEU - Assets


Neuren Pharmaceuticals reported AUD342.86M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Clinuvel Pharmaceuticals AUD 269.7M 2.05M Dec/2025
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Genetic Signatures AUD 49.04M 5.59M Dec/2025
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
Medical Developments International AUD 63.57M 2.83M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organon & Co USD 13.18B 182M Jun/2026
Paradigm Biopharmaceuticals AUD 23.15M 1.42M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Starpharma Holdings AUD 26.17M 746K Dec/2025
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Telix Pharmaceuticals AUD 1.36B 197.86M Jun/2026
Viatris USD 35.04B 1.79B Jun/2026
Xeris Pharmaceuticals USD 411.9M 19.89M Jun/2026